By Marcia Dunn

NASA held its first public meeting on UFOs Wednesday a year after launching a study into unexplained sightings.

The space agency televised the hourslong hearing featuring an independent panel of experts. The team includes 16 scientists and other experts selected by NASA including retired astronaut Scott Kelly, the first American to spend nearly a year in space.

Several committee members have been subjected to “online abuse” for serving on the team, which detracts from the scientific process, said NASA's Dan Evans, adding that NASA security is dealing with it.

“It’s precisely this rigorous, evidence-based approach that allows one to separate the fact from fiction," Evans said.

The study is a first step in trying to explain mysterious sightings in the sky that NASA calls UAPs, or unidentified aerial phenomena.

The group is looking at what unclassified information is available on the subject and how much more is needed to understand what's going on in the sky, according to astrophysicist David Spergel, the committee's chair who runs the Simons Foundation.

No secret military data are included, such as anything surrounding the suspected spy balloons from China spotted flying over the U.S. earlier this year.

The meeting was held at at NASA headquarters in Washington with the public taking part remotely.

A final report is expected by the end of July.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Share:
More In Science
One Good Thing: All 14 Patients in Experimental Trial Saw Cancer Go Into Remission
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
A New Plant-Based Way to Quit Smoking
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
Plant-Based Way to Quit Smoking; Innovation in Stroke Therapy
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
Load More